Biggest News Aggregation in the World
📰 Statement Regarding News

Page 48 - Statement Regarding News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Statement Regarding. Real-time updates on events, politics, business and more.

Defence Therapeutics Inc.: Breakthrough Results: Defence's Novel AccuTOX Intranasal Reduced 50% of Cancer Nodules on Animals with Lung Tumors

Vancouver, British Columbia--(Newsfile Corp. - December 20, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company
United Kingdom British Columbia Sebastien Plouffe Defence Therapeutics Inc British Columbia Newsfile Corp Precedence Research

EQS-News: Defence Therapeutics Inc.: BREAKTHROUGH RESULTS: DEFENCE'S NOVEL ACCUTOXTM INTRANASAL REDUCED 50% OF CANCER NODULES ON ANIMALS WITH LUNG TUMORS

EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous Defence Therapeutics Inc.: BREAKTHROUGH RESULTS: DEFENCE’S NOVEL ACCUTOXTM INTRANASAL REDUCED 50% OF CANCER NODULES ON ANIMALS WITH LUNG TUMORS 20.12.2022 / 08:00 CET/CEST The issuer is solely responsible for the content of this an...
British Columbia Sebastien Plouffe Defence Therapeutics Inc News Service Precedence Research Distribution Services

BREAKTHROUGH RESULTS: DEFENCE'S NOVEL ACCUTOXTM INTRANASAL REDUCED 50% OF CANCER NODULES ON ANIMALS WITH LUNG TUMORS

EQS-News: Defence Therapeutics Inc. / Key word(s): MiscellaneousBREAKTHROUGH RESULTS: DEFENCE’S NOVEL ACCUTOXTM INTRANASAL REDUCED 50% OF CANCER NODULES ON ANIMALS WITH LUNG TUMORS 20.12.2022 / 15:25 CET/CESTThe issuer is solely responsible for the content of this announcement.CSE: DTC       FSE:...
British Columbia Sebastien Plouffe Defence Therapeutics Inc Precedence Research Distribution Services Defence Therapeutics

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Defence Therapeutics Inc.: DEFENCE'S mRNA WITH ACCUMTM FOR CANCER VACCINES UPDATE

EQS-News: Defence Therapeutics Inc. / Key word(s): MiscellaneousDefence Therapeutics Inc.: DEFENCE'S mRNA WITH ACCUMTM FOR CANCER VACCINES UPDATE 15.12.2022 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. ________________________________________________________________...
British Columbia Sebastien Plouffe Defence Therapeutics Inc Precedence Research Distribution Services Defence Therapeutics

BioNxt Solutions Signs Term Sheet for Novel Precision Drug Coating Platform Technology

12.12.2022 - VANCOUVER, BC / ACCESSWIRE / December 12, 2022 / BioNxt Solutions Inc. (BioNxt or the Company) (CSE:XPHY)(OTC:XPHYF)(FSE:4XT) is pleased to report that it has signed a non-binding term sheet (the Term Sheet) for the acquisition of certain ...
United States Hugh Rogers Bionxt Solutions Inc Nxt Solutions North America Statement Regarding

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science